
The increasing resistance of mosquitoes to conventional insecticides and the environmental impacts associated with their use have stimulated interest in sustainable alternatives. Although chitosan has attracted attention as a biologically active and biodegradable biopolymer, the larvicidal efficacy of chitosan derived from the black soldier fly, Hermetia illucens, against Culex pipiens and its associated biochemical effects remain insufficiently characterized. This study aimed to evaluate the efficacy of an H. illucens-derived chitosan preparation against different mosquito developmental stages and investigate the biochemical responses associated with exposure. Chitosan was extracted from H. illucens larval exuviae through demineralization, deproteinization, and alkaline deacetylation. Its larvicidal activity was evaluated against different developmental stages of C. pipiens at concentrations of 25, 50, 100, and 200 µg/mL after 24 and 48 h of exposure. Lethal concentrations (LC₅₀, LC₉₀, and LC₉₅) were estimated using probit analysis. Larval and pupal survival were assessed after exposure of third-instar larvae to the 48-h LC₅₀, and changes in neuromuscular and digestive enzyme activities, antioxidant defenses, and oxidative stress biomarkers were measured in surviving larvae 24 h after exposure. The extracted chitosan preparation produced concentration- and time-dependent mortality across mosquito developmental stages. First-instar larvae were the most susceptible, whereas pupae were the least susceptible. For third-instar larvae, the LC₅₀ values were 26.09 µg/mL at 24 h and 25.53 µg/mL at 48 h. At the 48-h LC₅₀ exposure, larval and pupal survival declined to 53.0
The annual accumulation of vast quantities of poultry feather waste poses a significant global challenge to environmental sustainability and resource management. Feathers are protein-rich biomaterials; however, their highly recalcitrant β-keratin structure, stabilized by abundant disulfide bonds, renders them extremely resistant to degradation by conventional biological methods. This inherent recalcitrance contributes to persistent environmental hazards and represents a substantial loss of a potentially valuable biological resource. A novel feather-degrading actinobacterial strain was isolated from soil samples collected at a sea duck farm and identified as Streptomyces sp. 3–6 through integrated morphological, physiological-biochemical and genomic analyses. Optimum fermentation conditions were systematically determined using single factor experiments, Plackett-Burman (PB) screening, and orthogonal optimization, yielding the following parameters: feather, 25.0 g/L; yeast extract, 12.0 g/L; sucrose, 20.0 g/L; MgCl2, 4.0 g/L; initial pH, 10.0; and temperature, 30 °C. Under these conditions, strain 3–6 achieved near-complete feather degradation ( 90
The Trichoplusia ni-derived BTI-TN-5B1-4 (Tn5) cell line, commonly referred to as High Five™, is widely used for recombinant protein production because of its high productivity and strong secretion capacity in the baculovirus-insect cell expression system. However, adventitious viral contamination remains a significant concern, particularly in the manufacture of vaccines and therapeutic proteins, for which ensuring viral safety is paramount. In 2007, a latent infection with Tn5 Cell Line Virus (TnCLV), a member of the genus Alphanodavirus, was identified in Tn5 cells. Here, we report the discovery of a second adventitious virus, Bombyx mori macula-like virus (BmMLV), in the Tn5 cell line, and demonstrate that both viruses can be successfully eliminated using a co-culture protocol with Sf9 cells across a permeable membrane. Clonal cell lines were established from the resulting virus-free Tn5 cells and comprehensively characterized in serum-free suspension culture. Selected lines exhibited growth kinetics comparable to those of commercial High Five cells, supported productive baculovirus infection, and achieved recombinant protein yields comparable to or higher than those of High Five cells. These products included secreted alkaline phosphatase (SEAP), β-galactosidase (β-gal), the adenovirus penton-based virus-like particle ADDomer, and the malaria vaccine candidate PfRipr5. These new, fully traceable, virus-free cell lines provide an enhanced biosafety profile, potentially increasing their suitability for regulated biomanufacturing, and represent robust and reliable platforms for high-level recombinant protein production in both research and industrial applications.
The study investigated the extraction and characterization of gelatin from milkfish skin (Chanos chanos) using different pretreatment and extraction methods. The effects of acetic acid, combined sulfuric acid-acetic acid pretreatments, ultrasound-assisted extraction, and optimized multi-step extraction were evaluated. Extraction conditions significantly affected gelatin yield and functional properties. The highest yield (42.63 ± 1.63
Tendon, a dense connective tissue linking bone and skeletal muscle, is decellularized to generate tendon-derived Extracellular Matrix (dECM) – an increasingly utilized biomaterial for tendon repair. This study employed specific pathogen-free (SPF) Rongchang porcine tendons to optimize decellularization methodology. Decellularization efficacy was quantified through histological analysis and residual dsDNA quantification, while proteomic composition was compared across anatomical regions and developmental stages. A decellularized tendon matrix membrane (DTM) was subsequently fabricated. In vitro biocompatibility assessment confirmed that DTM does not induce severe erythrocyte hemolysis, exhibits no potential cytotoxicity, and shows significant upregulation of the tendon-specific markers Scx and Tnmd, while Col1α1 and Tnc remain unchanged. In vivo subcutaneous implantation revealed no gross rejection phenotype. These findings establish an optimized decellularization protocol and provide essential biomaterial characterization data for porcine tendon dECM development, offering critical insights for donor selection and clinical translation of tendon repair strategies.